North America Genome Editing Services (for Research Use Only) Market Size & Outlook
North America genome editing services market (for research use only), 2017-2028 (US$M)
Related Markets
North America genome editing services market (for research use only) highlights
- The North America genome editing services market (for research use only) generated a revenue of USD 393.0 million in 2020.
- The market is expected to grow at a CAGR of 22.6% from 2021 to 2028.
- In terms of segment, (crispr)/cas9 was the largest revenue generating technology in 2020.
- (CRISPR)/Cas9 is the most lucrative technology segment registering the fastest growth during the forecast period.
- Country-wise, Canada is expected to register the highest CAGR from 2021 to 2028.
North America data book summary
| Market revenue in 2020 | USD 393.0 million |
| Market revenue in 2028 | USD 2,004.2 million |
| Growth rate | 22.6% (CAGR from 2020 to 2028) |
| Largest segment | (crispr)/cas9 |
| Fastest growing segment | (CRISPR)/Cas9 |
| Historical data covered | 2017 - 2019 |
| Base year for estimation | 2020 |
| Forecast period covered | 2021 - 2028 |
| Quantitative units | Revenue in USD million |
| Market segmentation | (CRISPR)/Cas9, TALENs/MegaTALs, ZFN, Meganuclease |
| Key market players worldwide | Merck KGaA, Cibus Inc Ordinary Shares - Class A, Sangamo Therapeutics Inc, Editas Medicine Inc, Precision Diagnostics, CRISPR Therapeutics AG, Intellia Therapeutics Inc, Caribou Biosciences Inc Ordinary Shares, Cellectis SA, AstraZeneca PLC, Takara Bio Inc, Horizon Discovery, Danaher Corp, Genscript Biotech Corp Class H, New England Biolabs, Origin Enterprises PLC, Bluebird bio Inc, Lonza Group Ltd, Thermo Fisher Scientific Inc, Recombinetics, Transposagen Biopharmaceuticals |
Other key industry trends
- In terms of revenue, North America region accounted for 38.5% of the global genome editing services market (for research use only) in 2020.
- Globally, North America is projected to lead the regional market in terms of revenue in 2028.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 1,881.4 million by 2028.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Genome Editing Services Market (for Research Use Only) Scope
Genome Editing Services Market (for Research Use Only) Companies
| Name | Profile | # Employees | HQ | Website |
|---|
North America genome editing services market (for research use only) outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to genome editing services market (for research use only) will help companies and investors design strategic landscapes.
(crispr)/cas9 was the largest segment with a revenue share of 43.99% in 2020. Horizon Databook has segmented the North America genome editing services market (for research use only) based on (crispr)/cas9, talens/megatals, zfn, meganuclease covering the revenue growth of each sub-segment from 2017 to 2028.
Reasons to subscribe to North America genome editing services market (for research use only) databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of North America genome editing services market (for research use only) databook
-
Our clientele includes a mix of genome editing services market (for research use only) companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America genome editing services market (for research use only) , including forecasts for subscribers. This continent databook contains high-level insights into North America genome editing services market (for research use only) from 2017 to 2028, including revenue numbers, major trends, and company profiles.
Partial client list
North America genome editing services market (for research use only) size, by country, 2017-2028 (US$M)
North America Genome Editing Services Market (for Research Use Only) Outlook Share, 2020 & 2028 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
